Aldactone and Hyperkalemia - a phase IV clinical study of FDA data
Hyperkalemia is found among people who take Aldactone, especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months.
The phase IV clinical study analyzes which people take Aldactone and have Hyperkalemia. It is created by eHealthMe based on reports of 42,831 people who have side effects when taking Aldactone from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
42,831 people reported to have side effects when taking Aldactone.
Among them, 2,693 people (6.29%) have Hyperkalemia.
What is Aldactone?
Aldactone has active ingredients of spironolactone. It is often used in acne. eHealthMe is studying from 43,458 Aldactone users for its effectiveness, alternative drugs and more.
What is Hyperkalemia?
Hyperkalemia (damage to or disease of the kidney) is found to be associated with 3,126 drugs and 2,781 conditions by eHealthMe.
Number of Aldactone and Hyperkalemia reports submitted per year:
Time on Aldactone when people have Hyperkalemia *:
Gender of people who have Hyperkalemia when taking Aldactone*:
Age of people who have Hyperkalemia when taking Aldactone *:
Common drugs people take besides Aldactone *:
Common side effects people have besides Hyperkalemia *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Aldactone and have Hyperkalemia?Check whether Hyperkalemia is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Hyperkalemia and when was it recovered:
Expand to all the drugs that have ingredients of spironolactone:
- Hyperkalemia and drugs with ingredients of spironolactone (6,233 reports)
Alternative drugs to, pros and cons of Aldactone:
- Aldactone (43,458 reports)
Common Aldactone side effects:
- Breathing difficulty: 3,116 reports
- Hyperkalemia (damage to or disease of the kidney): 2,693 reports
- Hypotension (abnormally low blood pressure): 2,582 reports
- Diarrhea: 2,266 reports
- Fatigue (feeling of tiredness): 2,247 reports
- Weakness: 2,219 reports
Browse all side effects of Aldactone:a b c d e f g h i j k l m n o p q r s t u v w x y z
Hyperkalemia treatments and more:
- Hyperkalemia (70,817 reports)
COVID vaccines that are related to Hyperkalemia:
- Hyperkalemia in Moderna COVID Vaccine
- Hyperkalemia in Pfizer BioNTech Covid Vaccine
- Hyperkalemia in Johnson and Johnson Covid Vaccine
Common drugs associated with Hyperkalemia:
- Furosemide: 6,036 reports
- Metformin: 5,328 reports
- Spironolactone: 4,217 reports
- Aspirin: 4,200 reports
- Lasix: 3,990 reports
- Lisinopril: 3,919 reports
- Lopurin: 3,021 reports
- Allopurinol: 3,021 reports
- Amlodipine: 2,901 reports
- Aldactone: 2,693 reports
All the drugs that are associated with Hyperkalemia:
- Hyperkalemia (3,126 drugs)
Common conditions associated with Hyperkalemia:
- High blood pressure: 9,321 reports
- Type 2 diabetes: 2,927 reports
- Diabetes: 2,483 reports
- Pain: 1,908 reports
- Atrial fibrillation/flutter: 1,835 reports
All the conditions that are associated with Hyperkalemia:
- Hyperkalemia (2,781 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on spironolactone (the active ingredients of Aldactone) and Aldactone (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Hydroxychloroquine Sulfate and Ureteric Obstruction - now
- Rythmol and Hepatotoxicity Aggravated - a second ago
- Montelukast Sodium and Carbamazepine drug interaction - 9 seconds ago
- Rocaltrol and Aortic Valve Sclerosis - 23 seconds ago
- How effective is Allopurinol for Hyperuricaemia? - 23 seconds ago
- Rozerem and Delirium Tremens - 42 seconds ago
- Elidel and Gout - 44 seconds ago
- Diclofenac Potassium and Tumor - 46 seconds ago
- Mercaptopurine and Axonal Neuropathy - 49 seconds ago
- Itraconazole and Chickenpox - 51 seconds ago